Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. (2019)

First Author: Alexander M
Attributed to:  Stat2 is a therapeutic target in liver inflammation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12916-019-1321-x

PubMed Identifier: 31104631

Publication URI: http://europepmc.org/abstract/MED/31104631

Type: Journal Article/Review

Volume: 17

Parent Publication: BMC medicine

Issue: 1

ISSN: 1741-7015